Third, the differences in PFS and DoR observed between previously treated and newly diagnosed patients did not reach statistical significance, likely due to the limited sample size of the previously treated group, which reduced the statistical power.
← all excerpts
Thalidomide-based regimen shows promising efficacy in large granular lymphocytic leukemia: a multicenter phase II study.
1
—
—